請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32880
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 黃德富(Tur-Fu Huang) | |
dc.contributor.author | Chien-Hsin Chang | en |
dc.contributor.author | 張倩馨 | zh_TW |
dc.date.accessioned | 2021-06-13T04:17:59Z | - |
dc.date.available | 2006-08-02 | |
dc.date.copyright | 2006-08-02 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-25 | |
dc.identifier.citation | Abrams CS. (2005). Intracellular signaling in platelets. Curr Opin Hematol. 12:401-5.
Andrews RK, Berndt MC. (2004). Platelet physiology and thrombosis. Thromb Res. 114:447-53. Andrews RK, Kroll MH, Ward CM, Rose JW, Scarborough RM, Smith AI, Lopez JA, Berndt MC. (1996). Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 35:12629-39. Atkinson BT, Stafford MJ, Pears CJ, Watson SP. (2001). Signalling events underlying platelet aggregation induced by the glycoprotein VI agonist convulxin. Eur J Biochem. 268:5242-8. Bergmeier W, Bouvard D, Eble JA, Mokhtari-Nejad R, Schulte V, Zirngibl H, Brakebusch C, Fassler R, Nieswandt B. (2001). Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha. J Biol Chem. 276:25121-6. Born, GVR and Cross, MJ. (1963). The aggregation of blood platelet. J Physiol (London) 168: 178-95. Chang MC, Lin HK, Peng HC, Huang TF. (1998). Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox. Blood 91: 1582-9. Chen YL, Tsai IH. (1995). Functional and sequence characterization of agkicetin, a new glycoprotein Ib antagonist isolated from Agkistrodon acutus venom. Biochem Biophys Res Commun. 210:472-7. Chowdhury MA, Miyoshi S, Shinoda S. (1990). Purification and characterization of a protease produced by Vibrio mimicus. Infect Immun. 58:4159-62. Clark EA, Brugge JS. (1993). Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets. Mol Cell Biol. 13:1863-71. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. (1999). The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem. 274:29019-24. Clemetson KJ, Navdaev A, Dormann D, Du XY, Clemetson JM. (2001). Multifunctional snake C-type lectins affecting platelets. Haemostasis. 31:148-54. Dormann D, Clemetson JM, Navdaev A, Kehrel BE, Clemetson KJ. (2001). Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. Blood. 97:929-36. Du XY, Clemetson JM, Navdaev A, Magnenat EM, Wells TNC, Clemetson KJ. (2002). Ophioluxin, a convulxin-like C-type lectin from Ophiophagus hannah (King cobra) is a powerful platelet activator via glycoprotein VI. J Biol Chem. 277:35124-32. Du XY, Magnenat E, Wells TNC, Clemetson KJ. (2002). Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVI. Thromb Haemost 87:692-8. Du XY, Navdaev A, Clemetson JM, et al, Magnenat E, Wells TNC, Clemetson KJ. (2001). Bilinexin, a snake C-type lectin from Agkistrodon bilineatus venom agglutinates platelets via GPIb and α2β1. Thromb Haemost 86:1277-83. Faili A, Randon J, Francischetti IM, Vargaftig BB, Hatmi M. (1994). Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway. Biochem J. 298:87-91. Francischetti IM, Carlini CR, Guimaraes JA. (1998). cAMP does not inhibit convulxin-induced tyrosyl-phosphorylation of human platelet proteins, including PLCgamma2, but completely blocks the integrin alphaIIb beta3-dependent dephosphorylation step: comparisons with RGDS peptide, cytochalasin D, and phenylarsine oxide. Arch Biochem Biophys. 354:255-62. Francischetti IM, Ghazaleh FA, Reis RA, Carlini CR, Guimaraes JA. (1998). Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3. Arch Biochem Biophys. 353:239-50. Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T. (1995). Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost 74: 743-50. Fukuda K, Mizuno H, Atoda H, Morita T. (2000). Crystal structure of flavocetin-A, a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers. Biochemistry. 39:1915-23. Gibbins JM. (2004). Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci. 117:3415-25. Grynkiewicz G, Poenie M, Tsien RY. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:3440-50. Heino J. (2000). The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol. 19:319-23. Huang TF, Liu CZ, Yang SH. (1995). Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem J. 309:1021-7. Inoue K, Ozaki Y, Satoh K, Wu Y, Yatomi Y, Shin Y, Morita T. (1999). Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI. Biochem Biophys Res Commun. 256:114-20. Jurk K, Kehrel BE. (2005). Platelets: physiology and biochemistry. Semin Thromb Hemost. 31:381-92. Kanaji S, Kanaji T, Furihata K, Kato K, Ware JL, Kunicki TJ. (2003). Convulxin binds to native, human glycoprotein Ib alpha. J Biol Chem. 278:39452-60. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Knight CG, Farndale RW, Okuma M, Barnes MJ. (1998). Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 91:491-9. Kehrel B. (1995). Platelet-collagen interactions. Semin Thromb Hemost. 21:123-9. Kirby EP, Mills DC. (1975). The interaction of bovine factor VIII with human platelets. J Clin Invest. 56:491-502. Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-5. Lagrue AH, Francischetti IM, Guimaraes JA, Jandrot-Perrus M. (1999). Phosphatidylinositol 3'-kinase and tyrosine-phosphatase activation positively modulate Convulxin-induced platelet activation. Comparison with collagen. FEBS Lett. 448:95-100. Leduc M, Bon C. (1998). Cloning of subunits of convulxin, a collagen-like platelet-aggregating protein from Crotalus durissus terrificus venom. Biochem J. 333:389-93. Lee WH, Du XY, Lu QM, Clemetson KJ, Zhang Y. (2003). Stejnulxin, a novel snake C-type lectin-like protein from Trimeresurus stejnegeri venom is a potent platelet agonist acting specifically via GPVI. Thromb Haemost.90:662-71. Liu CZ, Wang YW, Shen MC, Huang TF. (1994). Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb Haemost. 72:919-25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951) Protein measurement with the Folin-phenol reagent. J Biol Chem. 193:265-75. Lu Q, Clemetson JM, Clemetson KJ. (2005). Snake venoms and hemostasis. J Thromb Haemost. 3:1791-9. Lu Q, Navdaev A, Clemetson JM, Clemetson KJ. (2004). GPIb is involved in platelet aggregation induced by mucetin, a snake C-type lectin protein from Chinese habu (Trimeresurus mucrosquamatus) venom. Thromb Haemost. 91:1168-76. Lu Q, Navdaev A, Clemetson JM, Clemetson KJ. (2005). Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis. Toxicon. 45:1089-98. Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B. (2003). A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med. 197:41-9. Moroi M, Jung SM. (2004). Platelet glycoprotein VI: its structure and function. Thromb Res. 114:221-33. Mustard JF, Perry DW, Ardlie NG, Packham MA. (1972). Preparation of suspensions of washed platelets from humans. Brit. J. Haematol. 22: 193-204. Navdaev A, Clemetson JM, Polgar J, Kehrel BE, Glauner M, Magnenat E, Wells TN, Clemetson KJ. (2001). Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (malayan pit viper), stimulates platelets by binding to alpha 2beta 1 integrin and glycoprotein Ib, activating Syk and phospholipase Cgamma 2, but does not involve the glycoprotein VI/Fc receptor gamma chain collagen receptor. J Biol Chem. 276:20882-9. Navdaev A, Dormann D, Clemetson JM, Clemetson KJ. (2001). Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction. Blood 97:2333-41. Moroi M, Jung SM. (2004). Platelet glycoprotein VI: its structure and function. Thromb Res. 114:221-33. Nieswandt B, Watson SP. (2003). Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449-61. Peng M, Lu W, Beviglia L, Niewiarowski S, Kirby EP. (1993). Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 81:2321-8. Peng M, Lu W, Kirby EP. (1992). Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb Haemost. 67:702-7. Polgar J, Clemetson JM, Kehrel BE, Wiedemann M, Magnenat EM, Wells TN, Clemetson KJ. (1997). Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem. 272:13576-83. Pollock WK, Rink TJ. (1986). Thrombin and ionomycin can raise platelet cytosolic Ca2+ to micromolar levels by discharge of internal Ca2+ stores: studies using fura-2. Biochem Biophys Res Commun. 139:308-14. Sakurai Y, Fujimura Y, Kokubo T, Imamura K, Kawasaki T, Handa M, Suzuki M, Matsui T, Titani K, Yoshioka A. (1998). The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom. Thromb Haemost. 79:1199-207. Staatz WD, Rajpara SM, Wayner EA, Carter WG, Santoro SA. (1989). The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol. 108:1917-24. Suzuki-Inoue K, Fuller GL, Garcia A, Eble JA, Pohlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing GD, Theakston RD, Schweighoffer E, Zitzmann N, Morita T, Tybulewicz VL, Ozaki Y, Watson SP. (2006). A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107:542-9. Swenson S, Markland FS Jr. (2005). Snake venom fibrin(ogen)olytic enzymes. Toxicon 45:1021-39. Taniuchi Y, Kawasaki T, Fujimura Y, Suzuki M, Titani K, Sakai Y, Kaku S, Hisamichi N, Satoh N, Takenaka T, et al. ( 1995). Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim Biophys Acta. 1244:331-8. Taniuchi Y, Kawasaki T, Fujimura Y. (2000). The high molecular mass, glycoprotein Ib-binding protein flavocetin-A induces only small platelet aggregates in vitro. Thromb Res. 97:69-75. Teng CM, Hung ML, Huang TF, Ouyang C. (1989). Triwaglerin: a potent platelet aggregation inducer purified from Trimeresurus wagleri snake venom. Biochim Biophys Acta. 992:258-64. Teng CM, Ko FN, Tsai IH, Hung ML, Huang TF. (1993). Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom. Thromb Haemost. 69:286-92. Wang R, Kini RM, Chung MC. (1999). Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (Malayan pit viper): synergistic and noncovalent interaction between its subunits. Biochemistry 38:7584-93. Wang WJ, Huang TF. (2001). A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. Thromb Haemost. 86:1077-86. Yeh CH, Chang MC, Peng HC, Huang TF. (2001). Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist. Br J Pharmacol. 132:843-50. Yip J, Shen Y, Berndt MC, Andrews RK. (2005). Primary platelet adhesion receptors. IUBMB Life. 57:103-8. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32880 | - |
dc.description.abstract | 出血性蛇毒蛋白能影響血液凝固和血小板凝集活性。在本實驗中,將Tropidolaemus wagleri原毒經由FPLC(fast performance liquid chromatography)之Mono S陽離子交換層析法以及Superdex-G200膠質過濾法進行純化分離,得到一具有引發血小板凝集之成分,命名為trowaglerix。以SDS-PAGE分析,發現在非還原狀態下,其分子量大於175 kDa;以膠質過濾法測定native分子量為212 kDa;在2D PAGE還原情形下,可見大約接近15 kDa的蛋白次單元。
Trowaglerix在人類血小板懸浮液(PS)和富含血小板血漿(PRP),皆會呈現濃度相關性地引起血小板凝集,其EC50分別為2.56±0.49和2.63±0.21 ng/ml。同樣地,Trowaglerix會劑量相關性地造成TxB2的產生、細胞內鈣離子的增加,以及血小板表面P-selectin的表現,且都在濃度為10 ng/ml時達飽和情形。PGE1、EDTA和BAPTA/AM會抑制trowaglerix引起的血小板凝集,但heparin、hirudin以及aprotinin卻不影響其作用,表示trowaglerix造成血小板凝集現象,並不是來自於thrombin或serine protease產生所引起的。Cytochalasin D會部分抑制trowaglerix引起的凝集(33.3±4.9 % inhibition),而indomethacin和CP/CPK只有些微的抑制作用。MEK抑制劑-PD98059不影響trowaglerix引起的凝集,PLC抑制劑-U73122和tyrosine kinase抑制劑-genistein有些微的抑制作用,而PI3-K抑制劑-LY294002和Syk抑制劑-piceatannol有較明顯的抑制情形;Src family kinase抑制劑-PP2會明顯地延長trowaglerix所造成的shape change,並有顯著的抑制trowaglerix所造成的凝集作用。 單獨使用GPIa/IIa拮抗劑(6F1)或GPIb拮抗劑(6D1)只能些微抑制trowaglerix引起的血小板凝集,即使兩者同時使用時也沒有太大的加成作用。Trowaglerix不會在福馬林固定之血小板上引起凝聚(agglutination)的情形。以流式細胞儀分析,GPIa/IIa單株抗體(6F1)、GPIb單株抗體(6D1、AP1)以及GPVI單株抗體(11A12)皆會部分抑制FITC-trowaglerix結合到血小板上;但利用biotinylated trowaglerix來觀察,發現它會專一性地結合到血小板表面上的GPVI上。此外,trowaglerix引起血小板訊息分子tyrosine磷酸化的情形類似convulxin所引起的,包括FcRγ chain、Src、Syk、LAT以及PLCγ2,當使用了Src family kinase抑制劑-PP2會全面性地抑制trowaglerix引起的訊息傳遞。將trowaglerix以靜脈注射方式打入ICR小鼠體內,發現會劑量相關性延長其尾巴出血時間,經測量小鼠血中血小板數目,發現trowaglerix同樣具有劑量相關性減少其體內的血小板數目。 綜合上述結果,Trowaglerix是一個具有高分子量的蛇毒蛋白,會專一性結合到血小板GPVI上,活化血小板後引起許多訊息分子的磷酸化,包括PLC γ2、PI3K、Syk、Src、LAT以及Fcγ,胞內游離鈣離子之增加和P-selectin表現,最後引發功能性αIIbβ3的表現,造成Ca2+依賴性的血小板凝集。由於trowaglerix的專一性,可以用來研究其與已知作用在GPVI的C-type lectins(i.e. convulxin、ophioluxin和stejnulxin)之間的差異,探討它們與GPVI分子層次之交互作用,提供GPVI拮抗劑之研發。亦可當作研究血小板上GPVI與其他受體(GPIb與GPIa/IIa)間之相關性的工具。 | zh_TW |
dc.description.abstract | Snake venoms profoundly affect platelet aggregation and blood coagulation. By using column chromatography of Mono-S cationic exchanger and Superdex-G200 gel filtration, a novel snake venom protein, trowaglerix, was purified from Tropidolaemus waglerix snake venom. Under non-reducing conditions, it migrates as a protein with a mass higher than 175 kDa on SDS-PAGE. The apparent molecular weight of native trowaglerix was estimated to be 212 kDa by gel filtration on FPLC/Superdex 200 column. Under reduction on 2D PAGE, it exhibits three subunits with similar masses close to 15 kDa.
Trowaglerix induced platelet aggregation of human washed platelets and platelet-rich plasma in a concentration-dependent manner with EC50, 2.56±0.49 and 2.63±0.21 ng/ml, respectively. Trowaglerix also triggered thromboxane B2 formation and the elevation of intracellular Ca2+ and the expression of P-selectin in a concentration-dependent and saturable manner. PGE1, EDTA, and BAPTA/AM completely inhibited trowaglerix-induced platelet aggregation. However, pretreatment of heparin, hirudin, or aprotinin did not significantly affect trowaglerix-induced platelet aggregation, indicating that trowaglerix-induced aggregation is independent of thrombin or serine protease formation. Cytochalasin D patially inhibited trowaglerix-induced platelet aggregation (33.3±4.9 % inhibition). ADP release reaction and thromboxane A2 formation had minor role in trowaglerix-induced platelet aggregation, because indomethacin and CP/CPK only had slight effect with 5.4±2.7 and 11.2±0.3 % inhibition, respectively. MEK inhibitor, PD98059 did not affect trowaglerix-induced platelet aggregation. PLC inhibitor, U73122 and tyrosine kinase inhibitor, genistein slightly inhibited trowaglerix-induced platelet aggregation. PI3-K inhibitor, LY294002 and Syk inhibitor, piceatannol had higher inhibitory effect. Src kinase inhibitor, PP2 significantly delayed the shape change and inhibited the aggregation induced by trowaglerix. Anti-GPIb mAb 6D1 and anti-GPIa/IIa mAb 6F1 only slightly inhibited platelet aggregation caused by trowaglerix. Even in combination, no additive inhibitory effect was observed. Trowaglerix did not elicit agglutination of fixed platelets. By flow cytometric analysis, we found that anti-GPIa/IIa mAb (6F1), anti-GPIb mAbs (6D1, AP1) and anti-GPVI mAb (11A12) displayed only a slight inhibition on the binding of FITC-trowaglerix to washed platelets. However, biotinylated trowaglerix specifically bound to GPVI, but not to GPIb or α2. In addition, trowaglerix induced a time-dependent tyrosine phosphorylation of a number of proteins similar to those activated by convulxin, including FcR γ chain, Src, Syk, LAT, and phospholipase Cγ2. PP2, a Src kinase inhibitor completely inhibited the tyrosine phosphorylation induced by trowaglerix. Intravenous injection of trowaglerix dose-dependently prolonged the bleeding time of ICR mice. Meanwhile, we also found that trowaglerix significantly decreased platelet count in a dose-dependent manner. Taken together, trowaglerix, a high molecular weight multimer of three subunits, activates platelets mainly through GPVI, leading to phosphorylation of many signal molecules, including PLCγ2, PI3K, Syk, Src, LAT and Fcγ, elevation of cytoplasmic Ca2+, P-selectin upregulation, and finally inducing the exposure of functional αIIbβ3 and Ca2+ -dependent platelet aggregation. This novel snake venom protein may provide an useful tool for studies of GPVI and signaling mechanisms involved as well as for comparative study with other C-type lectin GPVI agonists, like convulxin, ophioluxin and stejnulxin, and its association of platelet receptors, such as GPIb and GPIa/IIa. These studies would provide new insights regarding the molecular interaction of these GPVI agonists and GPVI, providing clues for the design of GPVI antagonists, a new class of antithrombotic agent. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T04:17:59Z (GMT). No. of bitstreams: 1 ntu-95-R93443004-1.pdf: 8751011 bytes, checksum: 2c448345d83d9e52f266a11e17a211f7 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | 1. 縮寫表…………………………………………………… 1
2. 中文摘要………………………………………………… 4 3. 英文摘要 ……………………………………………… 7 4. 緒論 …………………………………………………… 10 5. 實驗材料和方法 ……………………………………… 22 6. 實驗結果 ……………………………………………… 39 7. 結果圖表……………………………………………… 54 8. 討論…………………………………………………… 81 9. 參考文獻……………………………………………… 92 | |
dc.language.iso | zh-TW | |
dc.title | 蛇毒蛋白Trowaglerix之精製及其引發血小板
凝集機轉之探討 | zh_TW |
dc.title | Molecular Mechanisms of Trowaglerix, a Platelet Aggregation Inducer Purified from Snake Venom of Tropidolaemus wagleri | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄧哲明(Che-Ming Teng),顏茂雄(Mao-Hsiung Yen),楊春茂(Chuen-Mao Yang),王寧(Ling Wang) | |
dc.subject.keyword | 蛇毒,血小板凝集,Trowaglerix, | zh_TW |
dc.subject.keyword | snake venom,platelet aggregation,Trowaglerix, | en |
dc.relation.page | 99 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-25 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 8.55 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。